Nephron Pharmaceuticals announced a voluntary recall of ten lots of Albuterol Sulfate Inhalation Solution, 0.083% due to results from its internal monitoring processes. Albuterol Sulfate is a beta-2 agonist indicated for the management of bronchospasms.

RELATED: Respiratory Disorders Resource Center

The affected lots are as follows: Lot# A3A33A, A3A33B, A3A34A, A3A35A, A3A36A, A3A37A, A3A38A, A3A40A, A3A41A, and A3A42A.

All of the affected lots had passed Nephron’s quality specifications at the time of manufacturing, but the recall is being initiated as a precautionary measure. The product is supplied in a 25-count package and contains NDC# 0487-9501-25.

For more information call (800) 443-4314 or visit